Literature DB >> 30196753

Risk of Synchronous and Metachronous Colorectal Cancer: Population-Based Estimates in Denmark with Focus on Non-Hereditary Cases Diagnosed After Age 50.

L J Lindberg1, S Ladelund1, I Bernstein2, C Therkildsen1, M Nilbert1,3,4.   

Abstract

BACKGROUND AND AIMS: The risk of synchronous and metachronous colorectal cancer is influenced by heritable and environmental factors. As a basis for comparative studies, we provide population-based estimates of synchronous and metachronous colorectal cancer with a focus on non-heritable cases.
MATERIAL AND METHODS: Based on data from national Danish cancer registers, we estimated the proportion of synchronous colorectal cancer and the incidence rates and risks for metachronous colorectal cancer in 28,504 individuals, who developed 577 metachronous colorectal cancer above age 50.
RESULTS: Synchronous colorectal cancer was diagnosed in 1.3% of the cases. The risk of metachronous colorectal cancer was associated with sex, tumor location, and age with the strongest influence from the latter. The incidence rate ratios for metachronous colorectal cancer ranged from above 6 in patients below age 65 to <1-3.2 in patients above age 65. The absolute risk of metachronous colorectal cancer was ⩾10% in patients below age 65 and 1.0%-8.0% in patients above age 65.
CONCLUSION: Individuals who develop sporadic, non-inherited colorectal cancer above age 50 are at a significantly increased risk of metachronous colorectal cancer with risk estimates that are strongly affected by age. This observation underscores the need for development of targeted surveillance in the most common clinical subset of colorectal cancer.

Entities:  

Keywords:  Metachronous cancer; colon cancer; colorectal cancer; epidemiology; incidence; rectal cancer; second primary cancer

Mesh:

Year:  2018        PMID: 30196753     DOI: 10.1177/1457496918798212

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  3 in total

1.  Retrospective study of prognosis of patients with multiple colorectal carcinomas: synchronous versus metachronous makes the difference.

Authors:  Christoph Barz; Christian Stöss; Philipp-Alexander Neumann; Dirk Wilhelm; Klaus-Peter Janssen; Helmut Friess; Ulrich Nitsche
Journal:  Int J Colorectal Dis       Date:  2021-04-14       Impact factor: 2.571

2.  Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.

Authors:  Monika Vyas; Canan Firat; Jaclyn F Hechtman; Martin R Weiser; Rona Yaeger; Chad Vanderbilt; Jamal K Benhamida; Ajaratu Keshinro; Liying Zhang; Peter Ntiamoah; Marco Gonzalez; Rebecca Andrade; Imane El Dika; Arnold J Markowitz; J Joshua Smith; Julio Garcia-Aguilar; Efsevia Vakiani; David S Klimstra; Zsofia K Stadler; Jinru Shia
Journal:  Fam Cancer       Date:  2020-10-09       Impact factor: 2.446

3.  Oncogenic Features in Histologically Normal Mucosa: Novel Insights Into Field Effect From a Mega-Analysis of Colorectal Transcriptomes.

Authors:  Christopher H Dampier; Matthew Devall; Lucas T Jennelle; Virginia Díez-Obrero; Sarah J Plummer; Victor Moreno; Graham Casey
Journal:  Clin Transl Gastroenterol       Date:  2020-07       Impact factor: 4.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.